A personalized mRNA vaccine is showing breakthrough potential in pancreatic cancer treatment, significantly improving survival rates. By training the immune system to target and destroy cancer cells, the vaccine helps prevent recurrence after surgery. With some patients surviving up to 6 years, this innovation offers new hope in a disease known for poor prognosis and limited treatment options.